Related Experiment Video
Updated: Aug 13, 2026

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes
S Satoh1, A K Nüssler, Z Z Liu
1Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania 15213.
Insights
Hepatocytes can rapidly increase intercellular adhesion molecule-1 (ICAM-1) expression when exposed to inflammatory signals like cytokines. This finding clarifies how ICAM-1 contributes to inflammatory liver diseases.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Hepatocytes normally express low levels of intercellular adhesion molecule-1 (ICAM-1).
- ICAM-1 upregulation on hepatocytes is observed in inflammatory liver diseases, contributing to immune cell recruitment.
- Regulation of ICAM-1 expression in hepatocytes is not well understood.
Purpose of the Study:
- To investigate the regulation of ICAM-1 gene and protein expression in human hepatocytes.
- To identify specific inflammatory mediators that induce ICAM-1 expression in hepatocytes.
Main Methods:
- Primary human hepatocytes were cultured and stimulated with various cytokines (interleukin-1 beta, tumor necrosis factor-alpha, interferon-gamma) and endotoxin.
- ICAM-1 gene expression was measured using quantitative assays.
- ICAM-1 protein expression on the cell surface and in the culture medium was assessed via immunocytochemistry and enzyme immunoassay.
Main Results:
- Hepatocytes showed rapid induction of ICAM-1 gene expression within 30 minutes of stimulation.
- Interferon-gamma was a potent inducer, and cytokine combinations further enhanced expression.
- Maximal mRNA levels were observed within 10 hours, with protein detection by 12-24 hours.
Conclusions:
- Cytokines directly up-regulate ICAM-1 gene expression and protein secretion/shedding in human hepatocytes.
- This provides a direct mechanism linking inflammatory cytokines to ICAM-1 upregulation in liver disease.
- Findings clarify the role of hepatocytes in the inflammatory response within the liver.
Abstract:
Hepatocytes in normal tissues express low or undetectable levels of intercellular adhesion molecule-1 (ICAM-1), as detected by immunohistochemistry. Up-regulation of ICAM-1 expression on these cells has been reported in inflammatory liver disease (hepatitis B virus infection, autoimmune liver disorders and liver allograft rejection), and the molecule has been implicated in the recruitment, retention and activation of inflammatory cells. There is, however, little information concerning the regulation of hepatocyte expression of ICAM-1. We show here, for the first time, the induction (within 30 min) of ICAM-1 gene expression in cultured normal human hepatocytes stimulated with interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) or endotoxin. IFN-gamma was the most potent single inducer (up to fourfold at 6 hr), while further induction of ICAM-1 mRNA was achieved with cytokine combinations. Maximal mRNA expression was achieved within 10 hr. ICAM-1 could be detected readily by immunocytochemical staining on the hepatocyte surface by 12 hr, and by enzyme immunoassay in the culture medium by 24 hr. The data present clear evidence that cytokines, which have been implicated previously in inflammatory liver diseases, can up-regulate directly both ICAM-1 gene expression and protein secretion/shedding by human hepatocytes.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Gastritis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
Cirrhosis II: Pathophysiology

